337. ホモシスチン尿症 Homocystinuria Clinical trials / Disease details
臨床試験数 : 16 / 薬物数 : 19 - (DrugBank : 7) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 23
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04015557 (ClinicalTrials.gov) | February 11, 2022 | 28/5/2019 | Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria | Functional Consequences and Therapeutic Intervention in Hampered Production of Cysteine, Glutathione and Taurine in Classical Homocystinuria | CBS Deficiency | Drug: Acetaminophen;Drug: N-acetylcysteine | Hospital de Clinicas de Porto Alegre | Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil | Suspended | 18 Years | 65 Years | All | 10 | Phase 1/Phase 2 | Brazil |
| 2 | NCT01192828 (ClinicalTrials.gov) | January 2010 | 30/8/2010 | Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine | Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine | Homocystinuria | Drug: taurine | University of Colorado, Denver | NULL | Completed | 8 Years | 49 Years | All | 15 | Phase 1/Phase 2 | United States |